{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:34:17Z","timestamp":1777494857206,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18fk0210022"],"award-info":[{"award-number":["JP18fk0210022"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18fk0320041"],"award-info":[{"award-number":["JP18fk0320041"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the National Center for Global Health and Medicine"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Current serum hepatocellular carcinoma (HCC) biomarkers are insufficient for early diagnosis. We aimed to clarify whether serum MFG-E8 can serve as a diagnostic or prognostic biomarker of HCC. Serum MFG-E8 levels of 282 HCC patients, who underwent primary hepatectomy, were examined by ELISA. We also quantified serum MFG-E8 levels in patients with chronic hepatitis (CH), liver cirrhosis (LC), as well as in healthy volunteers (HVs). Serum MFG-E8 levels were significantly lower in HCC patients than in HVs regardless of the etiology of liver disease (3.6\u2009\u00b1\u20090.1 vs 5.8\u2009\u00b1\u20090.2\u2009ng\/mL, p\u2009&lt;\u20090.0001), and recovered after treatment of HCC. Serum MFG-E8 levels in CH and LC patients were comparable to those in HVs. Serum MFG-E8 could detect HCCs, even \u03b1-fetoprotein (AFP)-negative or des-\u03b3-carboxy prothrombin (DCP)-negative HCCs, in CH and LC patients. Our new HCC prediction model using MFG-E8 and DCP (Logit(<jats:italic>p<\/jats:italic>)\u2009=\u20092.619\u2009\u2212\u20090.809\u2009\u00d7\u2009serum MFG-E8\u2009+\u20090.0226\u2009\u00d7\u2009serum DCP) distinguished HCC patients from CH and LC patients with an area under the curve of 0.923, a sensitivity of 81.1%, and a specificity of 89.8%. Futhermore, low preoperative serum MFG-E8 was an independent predictor of poor overall survival. Thus, serum MFG-E8 could serve as a feasible diagnostic and prognostic biomarker for HCC.<\/jats:p>","DOI":"10.1038\/s41598-019-52356-6","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T11:08:43Z","timestamp":1572520123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Serum milk fat globule-EGF factor 8 (MFG-E8) as a diagnostic and prognostic biomarker in patients with hepatocellular carcinoma"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7257-3586","authenticated-orcid":false,"given":"Tomonari","family":"Shimagaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7860-6916","authenticated-orcid":false,"given":"Sachiyo","family":"Yoshio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironari","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzuru","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyoshi","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michitaka","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taizo","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moto","family":"Fukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Akita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5669-4051","authenticated-orcid":false,"given":"Junko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinobu","family":"Taketomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikinari","family":"Hanayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoharu","family":"Yoshizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Kanto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,31]]},"reference":[{"key":"52356_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136, E359\u2013386, https:\/\/doi.org\/10.1002\/ijc.29210 (2015).","journal-title":"Int J Cancer"},{"key":"52356_CR2","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095\u20132128 (2012).","journal-title":"Lancet"},{"key":"52356_CR3","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1053\/j.gastro.2004.09.023","volume":"127","author":"B Daniele","year":"2004","unstructured":"Daniele, B., Bencivenga, A., Megna, A. S. & Tinessa, V. \u03b1-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology 127, S108\u2013S112, https:\/\/doi.org\/10.1053\/j.gastro.2004.09.023 (2004).","journal-title":"Gastroenterology"},{"key":"52356_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/j.gastro.2009.04.005","volume":"137","author":"JA Marrero","year":"2009","unstructured":"Marrero, J. A. et al. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology 137, 110\u2013118, https:\/\/doi.org\/10.1053\/j.gastro.2009.04.005 (2009).","journal-title":"Gastroenterology"},{"key":"52356_CR5","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix, J. & Sherman, M., American Association for the Study of Liver, D. Management of hepatocellular carcinoma: an update. Hepatology 53, 1020\u20131022, https:\/\/doi.org\/10.1002\/hep.24199 (2011).","journal-title":"Hepatology"},{"key":"52356_CR6","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","volume":"2","author":"JM Llovet","year":"2016","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat Rev Dis Primers 2, 16018 (2016).","journal-title":"Nat Rev Dis Primers"},{"key":"52356_CR7","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1002\/hep.29254","volume":"66","author":"R Desert","year":"2017","unstructured":"Desert, R. et al. Human hepatocellular carcinomas with a periportal phenotype have the lowest potential for early recurrence after curative resection. Hepatology 66, 1502\u20131518, https:\/\/doi.org\/10.1002\/hep.29254 (2017).","journal-title":"Hepatology"},{"key":"52356_CR8","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/000313481107700516","volume":"77","author":"M Hayashi","year":"2011","unstructured":"Hayashi, M. et al. Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma. Am Surg 77, 572\u2013578 (2011).","journal-title":"Am Surg"},{"key":"52356_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jamcollsurg.2005.10.005","volume":"202","author":"SA Shah","year":"2006","unstructured":"Shah, S. A. et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 202, 275\u2013283, https:\/\/doi.org\/10.1016\/j.jamcollsurg.2005.10.005 (2006).","journal-title":"J Am Coll Surg"},{"key":"52356_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/hepr.12990","volume":"48","author":"T Shimagaki","year":"2018","unstructured":"Shimagaki, T. et al. MicroRNA-125b expression and intrahepatic metastasis are predictors for early recurrence after hepatocellular carcinoma resection. Hepatol Res 48, 313\u2013321, https:\/\/doi.org\/10.1111\/hepr.12990 (2018).","journal-title":"Hepatol Res"},{"key":"52356_CR11","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s10495-011-0630-0","volume":"16","author":"M Aziz","year":"2011","unstructured":"Aziz, M., Jacob, A., Matsuda, A. & Wang, P. Review: milk fat globule-EGF factor 8 expression, function and plausible signal transduction in resolving inflammation. Apoptosis 16, 1077\u20131086, https:\/\/doi.org\/10.1007\/s10495-011-0630-0 (2011).","journal-title":"Apoptosis"},{"key":"52356_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/417182a","volume":"417","author":"R Hanayama","year":"2002","unstructured":"Hanayama, R. et al. Identification of a factor that links apoptotic cells to phagocytes. Nature 417, 182\u2013187 (2002).","journal-title":"Nature"},{"key":"52356_CR13","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1126\/science.1094359","volume":"304","author":"R Hanayama","year":"2004","unstructured":"Hanayama, R. et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304, 1147\u20131150 (2004).","journal-title":"Science"},{"key":"52356_CR14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1172\/JCI83822","volume":"127","author":"M Nakaya","year":"2017","unstructured":"Nakaya, M. et al. Cardiac myofibroblast engulfment of dead cells facilitates recovery after myocardial infarction. J Clin Invest 127, 383\u2013401, https:\/\/doi.org\/10.1172\/JCI83822 (2017).","journal-title":"J Clin Invest"},{"key":"52356_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201211138","volume":"200","author":"G Raposo","year":"2013","unstructured":"Raposo, G. & Stoorvogel, W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200, 373\u2013383, https:\/\/doi.org\/10.1083\/jcb.201211138 (2013).","journal-title":"J Cell Biol"},{"key":"52356_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nri2567","volume":"9","author":"C Thery","year":"2009","unstructured":"Thery, C., Ostrowski, M. & Segura, E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9, 581\u2013593, https:\/\/doi.org\/10.1038\/nri2567 (2009).","journal-title":"Nat Rev Immunol"},{"key":"52356_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","volume":"2014","author":"M Colombo","year":"2014","unstructured":"Colombo, M., Raposo, G. & Th\u00e9ry, C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 2014, 255\u2013289, https:\/\/doi.org\/10.1146\/annurev-cellbio-101512-122326 (2014).","journal-title":"Annu Rev Cell Dev Biol"},{"key":"52356_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bone.2015.05.013","volume":"79","author":"IM Shapiro","year":"2015","unstructured":"Shapiro, I. M., Landis, W. J. & Risbud, M. V. Matrix vesicles: Are they anchored exosomes? Bone 79, 29\u201336, https:\/\/doi.org\/10.1016\/j.bone.2015.05.013 (2015).","journal-title":"Bone"},{"key":"52356_CR19","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","volume":"30","author":"A Becker","year":"2016","unstructured":"Becker, A. et al. Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis. Cancer Cell 30, 836\u2013848, https:\/\/doi.org\/10.1016\/j.ccell.2016.10.009 (2016).","journal-title":"Cancer Cell"},{"key":"52356_CR20","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1053\/j.gastro.2016.12.003","volume":"152","author":"SY An","year":"2017","unstructured":"An, S. Y. et al. Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice. Gastroenterology 152, 1174\u20131186, https:\/\/doi.org\/10.1053\/j.gastro.2016.12.003 (2017).","journal-title":"Gastroenterology"},{"key":"52356_CR21","doi-asserted-by":"publisher","first-page":"e5811","DOI":"10.1097\/MD.0000000000005811","volume":"96","author":"SJ Park","year":"2017","unstructured":"Park, S. J. et al. Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma. Medicine (Baltimore) 96, e5811, https:\/\/doi.org\/10.1097\/MD.0000000000005811 (2017).","journal-title":"Medicine (Baltimore)"},{"key":"52356_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep33935","volume":"6","author":"W Nakai","year":"2016","unstructured":"Nakai, W. et al. A novel affinity-based method for the isolation of highly purified extracellular vesicles. Sci Rep 6, 33935, https:\/\/doi.org\/10.1038\/srep33935 (2016).","journal-title":"Sci Rep"},{"key":"52356_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3233\/CBM-2007-3202","volume":"3","author":"ML Volk","year":"2007","unstructured":"Volk, M. L., Hernandez, J., Su, G. L., Lok, A. S. & Marrero, J. A. Risk factors for hepatocellular carcinoma may impair the performance of biomarkers- A comparison of AFP, DCP, and AFP-L3. Cancer Biomark 3, 79\u201387 (2007).","journal-title":"Cancer Biomark"},{"key":"52356_CR24","doi-asserted-by":"publisher","first-page":"10573","DOI":"10.3748\/wjg.v21.i37.10573","volume":"21","author":"N Tsuchiya","year":"2015","unstructured":"Tsuchiya, N. et al. Biomarkers for the early diagnosis of hepatocellular carcinoma. World J Gastroenterol 21, 10573\u201310583, https:\/\/doi.org\/10.3748\/wjg.v21.i37.10573 (2015).","journal-title":"World J Gastroenterol"},{"key":"52356_CR25","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.2147\/CMAR.S167036","volume":"10","author":"H Chen","year":"2018","unstructured":"Chen, H. et al. Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma. Cancer Manag Res 10, 1947\u20131958, https:\/\/doi.org\/10.2147\/CMAR.S167036 (2018).","journal-title":"Cancer Manag Res"},{"key":"52356_CR26","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1016\/S0168-8278(12)60009-9","volume":"56","author":"CR de Lope","year":"2012","unstructured":"de Lope, C. R., Tremosini, S., Forner, A., Reig, M. & Bruix, J. Management of HCC. J Hepatol 56, S75\u201387 (2012).","journal-title":"J Hepatol"},{"key":"52356_CR27","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag, H. B. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142, 1264\u20131273 e1261, https:\/\/doi.org\/10.1053\/j.gastro.2011.12.061 (2012).","journal-title":"Gastroenterology"},{"key":"52356_CR28","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S1470-2045(09)70241-4","volume":"10","author":"D Poon","year":"2009","unstructured":"Poon, D. et al. Asian Oncology Summit. Management of hepatocellular carcinoma in Asia- consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 10, 1111\u20131118 (2009).","journal-title":"Lancet Oncol"},{"key":"52356_CR29","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/SLA.0b013e3182111195","volume":"253","author":"ST Fan","year":"2011","unstructured":"Fan, S. T. et al. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg 253, 745\u2013758, https:\/\/doi.org\/10.1097\/SLA.0b013e3182111195 (2011).","journal-title":"Ann Surg"},{"key":"52356_CR30","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/hep.25832","volume":"57","author":"S Roayaie","year":"2013","unstructured":"Roayaie, S. et al. Resection of hepatocellular cancer <\/=2 cm: results from two Western centers. Hepatology 57, 1426\u20131435, https:\/\/doi.org\/10.1002\/hep.25832 (2013).","journal-title":"Hepatology"},{"key":"52356_CR31","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.jhep.2009.12.037","volume":"52","author":"A Cucchetti","year":"2010","unstructured":"Cucchetti, A. et al. Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network- A pilot study. J Hepatol 52, 880\u2013888 (2010).","journal-title":"J Hepatol"},{"key":"52356_CR32","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1245\/s10434-016-5520-9","volume":"23","author":"PC Lee","year":"2016","unstructured":"Lee, P. C. et al. Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection. Ann Surg Oncol 23, 874\u2013883 (2016).","journal-title":"Ann Surg Oncol"},{"key":"52356_CR33","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/jbmr.2721","volume":"31","author":"E Albus","year":"2016","unstructured":"Albus, E. et al. Milk Fat Globule-Epidermal Growth Factor 8 (MFG-E8) Is a Novel Anti-inflammatory Factor in Rheumatoid Arthritis in Mice and Humans. J Bone Miner Res 31, 596\u2013605, https:\/\/doi.org\/10.1002\/jbmr.2721 (2016).","journal-title":"J Bone Miner Res"},{"key":"52356_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cca.2017.01.013","volume":"466","author":"G Sun","year":"2017","unstructured":"Sun, G. et al. Reduced serum milk fat globule-epidermal growth factor 8 (MFG-E8) concentrations are associated with an increased risk of microvascular complications in patients with type 2 diabetes. Clin Chim Acta 466, 201\u2013206, https:\/\/doi.org\/10.1016\/j.cca.2017.01.013 (2017).","journal-title":"Clin Chim Acta"},{"key":"52356_CR35","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1189\/jlb.1107730","volume":"83","author":"H Yamaguchi","year":"2008","unstructured":"Yamaguchi, H. et al. Milk fat globule EGF factor 8 in the serum of human patients of systemic lupus erythematosus. J Leukoc Biol 83, 1300\u20131307, https:\/\/doi.org\/10.1189\/jlb.1107730 (2008).","journal-title":"J Leukoc Biol"},{"key":"52356_CR36","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1126\/science.1153124","volume":"319","author":"K Trajkovic","year":"2008","unstructured":"Trajkovic, K. et al. Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes. Science 319, 1244\u20131247 (2008).","journal-title":"Science"},{"key":"52356_CR37","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.1021\/bi963119m","volume":"36","author":"MH Andersen","year":"1997","unstructured":"Andersen, M. H., Berglund, L., Rasmussen, J. T. & Petersen, T. E. Bovine PAS-6\/7 Binds \u03b1v\u03b25 Integrin and Anionic Phospholipids through Two Domains. Biochemistry 36, 5441\u20135446 (1997).","journal-title":"Biochemistry"},{"key":"52356_CR38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bcmd.2005.05.001","volume":"35","author":"P Veron","year":"2005","unstructured":"Veron, P., Segura, E., Sugano, G., Amigorena, S. & Thery, C. Accumulation of MFG-E8\/lactadherin on exosomes from immature dendritic cells. Blood Cells Mol Dis 35, 81\u201388, https:\/\/doi.org\/10.1016\/j.bcmd.2005.05.001 (2005).","journal-title":"Blood Cells Mol Dis"},{"key":"52356_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13046-018-0691-9","volume":"37","author":"Z Lin","year":"2018","unstructured":"Lin, Z. et al. Integrin-beta5, a miR-185-targeted gene, promotes hepatocellular carcinoma tumorigenesis by regulating beta-catenin stability. J Exp Clin Cancer Res 37, 17, https:\/\/doi.org\/10.1186\/s13046-018-0691-9 (2018).","journal-title":"J Exp Clin Cancer Res"},{"key":"52356_CR40","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/carcin\/bgi022","volume":"26","author":"R Mayoral","year":"2005","unstructured":"Mayoral, R., Fernandez-Martinez, A., Bosca, L. & Martin-Sanz, P. Prostaglandin E2 promotes migration and adhesion in hepatocellular carcinoma cells. Carcinogenesis 26, 753\u2013761, https:\/\/doi.org\/10.1093\/carcin\/bgi022 (2005).","journal-title":"Carcinogenesis"},{"key":"52356_CR41","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1053\/jhep.2002.34611","volume":"36","author":"M Nejjari","year":"2002","unstructured":"Nejjari, M. et al. Expression, regulation, and function of alpha V integrins in hepatocellular carcinoma: an in vivo and in vitro study. Hepatology 36, 418\u2013426, https:\/\/doi.org\/10.1053\/jhep.2002.34611 (2002).","journal-title":"Hepatology"},{"key":"52356_CR42","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nature06307","volume":"450","author":"M Miyanishi","year":"2007","unstructured":"Miyanishi, M. et al. Identification of Tim4 as a phosphatidylserine receptor. Nature 450, 435\u2013439, https:\/\/doi.org\/10.1038\/nature06307 (2007).","journal-title":"Nature"},{"key":"52356_CR43","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Thery","year":"2018","unstructured":"Thery, C. et al. Minimal Information for Studies of Extracellular Vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 7, 1535750, https:\/\/doi.org\/10.1080\/20013078.2018.1535750 (2018).","journal-title":"J Extracell Vesicles"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52356-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52356-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52356-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T15:15:14Z","timestamp":1671290114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52356-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,31]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["52356"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-52356-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,31]]},"assertion":[{"value":"21 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research has been funded by the Program for Basic and Clinical Research on Hepatitis (AMED) (JP18fk0210022 and JP18fk0320041) and the National Center for Global Health and Medicine (29-shi-1007). Tatsuya Kanto received lecture fees from Gilead Scienes, Merk Sharp & Dohme. In addition, other authors have no competing interests as defined by Nature Research, or other interests that might be perceived to influence the results and\/or discussion reported in this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15788"}}